- Home
- IRTC vs RGC Comparison
IRTC vs RGC Comparison
Compare IRTC & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IRTC | RGC |
|---|---|---|
| Founded | 2006 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.1B |
| IPO Year | 2016 | 2020 |
Fundamental Metrics
Financial Performance| Metric | IRTC | RGC |
|---|---|---|
| Price | $109.33 | $9.73 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $172.14 | N/A |
| AVG Volume (30 Days) | ★ 449.9K | 221.5K |
| Earning Date | 11-05-2026 | 10-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.71 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $747,138,000.00 | N/A |
| Revenue This Year | $19.40 | N/A |
| Revenue Next Year | $16.65 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 26.24 | N/A |
| 52 Week Low | $100.70 | $4.51 |
| 52 Week High | $210.01 | $69.00 |
Technical Indicators
Market Signals| Indicator | IRTC | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 48.85 | 78.76 |
| Support Level | $107.33 | $4.97 |
| Resistance Level | $117.56 | $29.26 |
| Average True Range (ATR) | 3.63 | 0.99 |
| MACD | 0.44 | 0.29 |
| Stochastic Oscillator | 66.94 | 75.30 |
Price Performance
Historical ComparisonAbout IRTC iRhythm Technologies Inc.
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.